RealPennies.com: Turning Pennies into dollars: (OTC:DMYDY) Diamyd Medical AB

RealPennies.com: Turning Pennies into dollars: (OTC:DMYDY) Diamyd Medical AB



Are you a public company looking for exposure?

Contact RealPennies.com - 212-662-2147



For more info: http://dmydy.realpennies.com/

(OTC:DMYDY) Diamyd Medical AB

Diamyd Medical: Diamyd Medical's NTDDS Technology Effective against Diabetes Pain

Monday September 1, 2:46 am ET

STOCKHOLM, Sweden-Regulatory News:

Diamyd Medical reports that its Nerve Targeting Drug Delivery System expressing enkephalin, is effective in preclinical models of diabetes pain.

Profile for Diamyd Medical AB

Diamyd Medical AB, a life science company, through its subsidiaries, develops therapeutic products for diabetes and its complications. The company develops therapeutics from two independent platform technologies: Therapeutic rights to the gene coding for human Glutamic Acid Decarboxylase 65 kDa isoform (GAD65) and Nerve Targeted Drug Delivery System (NTDDS). Its principal product includes Diamyd (a phase II completed product), a GAD65 based therapeutic vaccine for patients with newly-diagnosed type 1 diabetes and for the patients with autoimmune type 2 diabetes known as Latent Autoimmune Diabetes in adults. The NTDDS lead projects comprise therapeutics for treating pain using Enkephalin (NP2...

Detailed Description...



http://www.realpennies.com/start.html



Any opinions expressed herein are statements of our judgment as of the date of publication and are subject to change without notice. Reproduction without written permission is prohibited.



RealPennies .

Telephone: 212-662-2147

info [at] realpennies.com